Libai Foundation - Health Built Different.
● Breaking
NICE backs non-hormonal treatment for hot flashes
● Top Story
Mental Wellness

NICE backs non-hormonal treatment for hot flashes

NICE backs a non hormonal treatment for hot flashes and night sweats, approving the daily 45-mg fezolinetant tablet (Veoza) for NHS patients on March 11, 2026.

Clinical Findings

New Pharmacy Technician Curriculum Risks Higher Dropouts

The pharmacy technician curriculum revisions warned by the CCA may increase student…

Clinical Findings

Government slow to act on valproate redress

Government slow to act on sodium valproate redress, addressing harms caused to…

Research Briefs

MHRA Issues Recall on ACE Inhibitor Blister Packs

The MHRA issues a recall on specific ACE inhibitor blister packs due…

Mental Wellness

Scottish pharmacists boost menopause support with peer-led clinics

Scottish pharmacists launch peer-led menopause clinics to improve women’s understanding and confidence…

Mental Wellness

More →
NICE backs non-hormonal treatment for hot flashes
Mental Wellness

NICE backs non-hormonal treatment for hot flashes

Mental Wellness

Scottish pharmacists boost menopause support with peer-led clinics

Mental Wellness

Scotland launches first drug-checking service

Mental Wellness

Prescribing error blamed in infant death sparks safety review

Clinical Findings

More →
New Pharmacy Technician Curriculum Risks Higher Dropouts
Clinical Findings

New Pharmacy Technician Curriculum Risks Higher Dropouts

Clinical Findings

Government slow to act on valproate redress

Clinical Findings

UK pharmacies to get fairer funding

Clinical Findings

NFL Players’ CTE Rate at 75% in New Study

Policy Watch

More →
The Ceiling Decision That Shapes the Whole Interior: A Guide to Better False Ceiling Choices
Policy Watch

Rural heart attack patients far more likely to die

Policy Watch

New tech aids mental health diagnosis

Policy Watch

New AI tool distinguishes epilepsy from functional seizures

Patient Advocacy

More →
NHS to offer Enhertu to breast cancer patients
Patient Advocacy

NHS to offer Enhertu to breast cancer patients

Patient Advocacy

Former Star Pitcher Urges Cholesterol Checks After Heart Procedure

Patient Advocacy

Anxiety Affects One Fifth of U.S. Young Adults

Patient Advocacy

Smartphone use hurts teens sleep patterns

Research Briefs

More →
MHRA Issues Recall on ACE Inhibitor Blister Packs
Research Briefs

MHRA Issues Recall on ACE Inhibitor Blister Packs

Research Briefs

Liberal Democrats vow to boost Pharmacy First service

Research Briefs

Pharmacies Expect Surge in Weight Loss Pill Demand

Research Briefs

Kids on GLP-1 Drugs Face Nutritional Deficiency Risks